EUVIMEDEUVIMED entdecken
Crossref

A Case of ALK Fusion Gene-positive Primary Lung Adenocarcinoma with Signet-ring Cell Morphology Treated with an Immune Checkpoint Inhibitor and ALK Tyrosine Kinase Inhibitor

Yasuhito Hosoda, Jun Yanagisawa, Kozue Nakahara, Kazuo Inada, Kiyotaka Miura, Yuko Goto, Kazuki Nabeshima

Haigan · 20.04.2026 · 66 (2) · 108-113

DOI: 10.2482/haigan.66.108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Yasuhito Hosoda und 6 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hosoda, Y., Yanagisawa, J., Nakahara, K., Inada, K., Miura, K., Goto, Y., & Nabeshima, K. (2026). A Case of ALK Fusion Gene-positive Primary Lung Adenocarcinoma with Signet-ring Cell Morphology Treated with an Immune Checkpoint Inhibitor and ALK Tyrosine Kinase Inhibitor. Haigan, 66(2), 108-113. https://doi.org/10.2482/haigan.66.108

Vancouver

Hosoda Y, Yanagisawa J, Nakahara K, Inada K, Miura K, Goto Y, et al. A Case of ALK Fusion Gene-positive Primary Lung Adenocarcinoma with Signet-ring Cell Morphology Treated with an Immune Checkpoint Inhibitor and ALK Tyrosine Kinase Inhibitor. Haigan. 2026;66(2):108-113. doi:10.2482/haigan.66.108

BibTeX
@article{Hosoda2026,
  author = {Hosoda, Yasuhito and Yanagisawa, Jun and Nakahara, Kozue and Inada, Kazuo and Miura, Kiyotaka and Goto, Yuko and Nabeshima, Kazuki},
  title = {A Case of ALK Fusion Gene-positive Primary Lung Adenocarcinoma with Signet-ring Cell Morphology Treated with an Immune Checkpoint Inhibitor and ALK Tyrosine Kinase Inhibitor},
  journal = {Haigan},
  year = {2026},
  volume = {66},
  number = {2},
  pages = {108--113},
  doi = {10.2482/haigan.66.108}
}
Kostenlos starten →